225 related articles for article (PubMed ID: 27613872)
1. Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin.
Shearer AM; Rana R; Austin K; Baleja JD; Nguyen N; Bohm A; Covic L; Kuliopulos A
J Biol Chem; 2016 Oct; 291(44):23188-23198. PubMed ID: 27613872
[TBL] [Abstract][Full Text] [Related]
2. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins.
Sevigny LM; Zhang P; Bohm A; Lazarides K; Perides G; Covic L; Kuliopulos A
Proc Natl Acad Sci U S A; 2011 May; 108(20):8491-6. PubMed ID: 21536878
[TBL] [Abstract][Full Text] [Related]
3. PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.
Barr TP; Garzia C; Guha S; Fletcher EK; Nguyen N; Wieschhaus AJ; Ferrer L; Covic L; Kuliopulos A
J Invest Dermatol; 2019 Feb; 139(2):412-421. PubMed ID: 30287285
[TBL] [Abstract][Full Text] [Related]
4. PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease.
Rana R; Shearer AM; Fletcher EK; Nguyen N; Guha S; Cox DH; Abdelmalek M; Wang Y; Baleja JD; Covic L; Kuliopulos A
Mol Metab; 2019 Nov; 29():99-113. PubMed ID: 31668396
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside Alleviates Hepatic Fibrosis Function via PAR2 Signaling Pathway in Diabetic Rats.
Wang Z; Li Q; Xiang M; Zhang F; Wei D; Wen Z; Zhou Y
Cell Physiol Biochem; 2017; 41(3):1156-1166. PubMed ID: 28245465
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-2 modulates hepatic stellate cell collagen release and apoptotic status.
Li JL; Cai WS; Shen F; Feng Z; Zhu GH; Cao J; Xu B
Arch Biochem Biophys; 2014 Mar; 545():162-6. PubMed ID: 24495782
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
8. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P
Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932
[TBL] [Abstract][Full Text] [Related]
10. Curcumin limits the fibrogenic evolution of experimental steatohepatitis.
Vizzutti F; Provenzano A; Galastri S; Milani S; Delogu W; Novo E; Caligiuri A; Zamara E; Arena U; Laffi G; Parola M; Pinzani M; Marra F
Lab Invest; 2010 Jan; 90(1):104-15. PubMed ID: 19901911
[TBL] [Abstract][Full Text] [Related]
11. PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference.
Shearer AM; Wang Y; Fletcher EK; Rana R; Michael ES; Nguyen N; Abdelmalek MF; Covic L; Kuliopulos A
Hepatology; 2022 Dec; 76(6):1778-1793. PubMed ID: 35603482
[TBL] [Abstract][Full Text] [Related]
12. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
[TBL] [Abstract][Full Text] [Related]
14. Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation.
Hu J; Zheng Y; Ying H; Ma H; Li L; Zhao Y
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145172
[TBL] [Abstract][Full Text] [Related]
15. Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.
Wieser V; Adolph TE; Enrich B; Kuliopulos A; Kaser A; Tilg H; Kaneider NC
Gut; 2017 May; 66(5):930-938. PubMed ID: 26858343
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
17. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
[TBL] [Abstract][Full Text] [Related]
20. Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease.
Lee KC; Hsieh YC; Chan CC; Sun HJ; Huang YH; Hou MC; Lin HC
Lab Invest; 2019 Jul; 99(8):1203-1216. PubMed ID: 30918325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
